Literature DB >> 17606758

The big idea: the coxib crisis iron, aspirin and heart disease risk revisited.

Jerome L Sullivan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17606758      PMCID： PMC1905876          DOI： 10.1177/014107680710000721

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  19 in total

1.  Arthritis medicines and cardiovascular events--"house of coxibs".

Authors:  Eric J Topol
Journal:  JAMA       Date:  2004-12-28       Impact factor: 56.272

2.  Stored iron and vascular reactivity.

Authors:  Jerome L Sullivan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08       Impact factor: 8.311

3.  NEJM "failed its readers" by delay in publishing its concerns about VIGOR trial.

Authors:  Roger Dobson
Journal:  BMJ       Date:  2006-07-15

4.  Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial.

Authors:  M Catalano; G Born; R Peto
Journal:  J Intern Med       Date:  2007-03       Impact factor: 8.989

Review 5.  Cyclooxygenase inhibition and cardiovascular risk.

Authors:  Elliott M Antman; David DeMets; Joseph Loscalzo
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

6.  Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques.

Authors:  Domenico Lapenna; Sante D Pierdomenico; Giuliano Ciofani; Sante Ucchino; Matteo Neri; Maria Adele Giamberardino; Franco Cuccurullo
Journal:  Free Radic Biol Med       Date:  2006-11-17       Impact factor: 7.376

7.  Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.

Authors:  Christopher P Cannon; Sean P Curtis; James A Bolognese; Loren Laine
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

8.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

9.  Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence Of blood donation, alcohol intake, and iron supplementation.

Authors:  N Milman; L Ovesen; K Byg; N Graudal
Journal:  Ann Hematol       Date:  1999-09       Impact factor: 3.673

10.  Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.

Authors:  Leo R Zacharski; Bruce K Chow; Paula S Howes; Galina Shamayeva; John A Baron; Ronald L Dalman; David J Malenka; C Keith Ozaki; Philip W Lavori
Journal:  JAMA       Date:  2007-02-14       Impact factor: 56.272
View more
  1 in total

1.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.